KCNN4

KCNN4
Identifiers
Aliases KCNN4, IK1, IKCA1, KCA4, KCa3.1, SK4, hIKCa1, hKCa4, hSK4, IK, DHS2, potassium calcium-activated channel subfamily N member 4
External IDs MGI: 1277957 HomoloGene: 1696 GeneCards: KCNN4
Targeted by Drug
chlorzoxazone, riluzole, clotrimazole, nitrendipine, senicapoc[1]
RNA expression pattern
More reference expression data
Orthologs
Species Human Mouse
Entrez

3783

16534

Ensembl

ENSG00000104783

ENSMUSG00000054342

UniProt

O15554

O89109

RefSeq (mRNA)

NM_002250

NM_001163510
NM_008433

RefSeq (protein)

NP_002241.1

NP_001156982.1
NP_032459.3

Location (UCSC) Chr 19: 43.77 – 43.78 Mb Chr 7: 24.37 – 24.39 Mb
PubMed search [2] [3]
Wikidata
View/Edit HumanView/Edit Mouse

Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4, also known as KCNN4, is a human gene encoding the KCa3.1 protein.[4]

Function

The KCa3.1 protein is part of a potentially heterotetrameric voltage-independent potassium channel that is activated by intracellular calcium. Activation is followed by membrane hyperpolarization, which promotes calcium influx. The encoded protein may be part of the predominant calcium-activated potassium channel in T-lymphocytes. This gene is similar to other KCNN family potassium channel genes, but it differs enough to possibly be considered as part of a new subfamily.[4]

History

The channel activity was first described in 1958 by Gyorgi Gardos in human erythrocytes.[5] The channels is also named Gardos channel because of its discoverer.

See also

References

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.


This article is issued from Wikipedia - version of the 10/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.